Pharma & Healthcare
Global Anti-HIV-1 Drugs Market Research Report 2025
- Apr 16, 25
- ID: 195575
- Pages: 87
- Figures: 87
- Views: 50
The global market for Anti-HIV-1 Drugs was valued at US$ 30210 million in the year 2024 and is projected to reach a revised size of US$ 46370 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Anti-HIV-1 drugs are antiviral medications designed to inhibit the replication of Human Immunodeficiency Virus Type 1 (HIV-1), the predominant strain of HIV responsible for Acquired Immunodeficiency Syndrome (AIDS). These drugs help reduce viral load, prevent disease progression, and decrease the risk of HIV transmission.
North American market for Anti-HIV-1 Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-HIV-1 Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-HIV-1 Drugs include Gilead Sciences, GSK, Merck Sharp & Dohme, Cipla, Frontier Biotechnologies, Jiangsu Aidea Pharmaceutical, Ascletis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-HIV-1 Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-HIV-1 Drugs.
The Anti-HIV-1 Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-HIV-1 Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-HIV-1 Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
GSK
Merck Sharp & Dohme
Cipla
Frontier Biotechnologies
Jiangsu Aidea Pharmaceutical
Ascletis
Segment by Type
Oral Drugs
Injectable Drugs
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-HIV-1 Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-HIV-1 Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-HIV-1 drugs are antiviral medications designed to inhibit the replication of Human Immunodeficiency Virus Type 1 (HIV-1), the predominant strain of HIV responsible for Acquired Immunodeficiency Syndrome (AIDS). These drugs help reduce viral load, prevent disease progression, and decrease the risk of HIV transmission.
North American market for Anti-HIV-1 Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-HIV-1 Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-HIV-1 Drugs include Gilead Sciences, GSK, Merck Sharp & Dohme, Cipla, Frontier Biotechnologies, Jiangsu Aidea Pharmaceutical, Ascletis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-HIV-1 Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-HIV-1 Drugs.
The Anti-HIV-1 Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-HIV-1 Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-HIV-1 Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
GSK
Merck Sharp & Dohme
Cipla
Frontier Biotechnologies
Jiangsu Aidea Pharmaceutical
Ascletis
Segment by Type
Oral Drugs
Injectable Drugs
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-HIV-1 Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-HIV-1 Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Anti-HIV-1 Drugs Market Overview
1.1 Product Definition
1.2 Anti-HIV-1 Drugs by Type
1.2.1 Global Anti-HIV-1 Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Drugs
1.2.3 Injectable Drugs
1.3 Anti-HIV-1 Drugs by Application
1.3.1 Global Anti-HIV-1 Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Anti-HIV-1 Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-HIV-1 Drugs Revenue 2020-2031
1.4.2 Global Anti-HIV-1 Drugs Sales 2020-2031
1.4.3 Global Anti-HIV-1 Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-HIV-1 Drugs Market Competition by Manufacturers
2.1 Global Anti-HIV-1 Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-HIV-1 Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-HIV-1 Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-HIV-1 Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-HIV-1 Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-HIV-1 Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-HIV-1 Drugs, Date of Enter into This Industry
2.8 Global Anti-HIV-1 Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-HIV-1 Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-HIV-1 Drugs Players Market Share by Revenue
2.8.3 Global Anti-HIV-1 Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-HIV-1 Drugs Market Scenario by Region
3.1 Global Anti-HIV-1 Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-HIV-1 Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-HIV-1 Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-HIV-1 Drugs Sales by Region: 2026-2031
3.3 Global Anti-HIV-1 Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-HIV-1 Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-HIV-1 Drugs Revenue by Region: 2026-2031
3.4 North America Anti-HIV-1 Drugs Market Facts & Figures by Country
3.4.1 North America Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-HIV-1 Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-HIV-1 Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-HIV-1 Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-HIV-1 Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-HIV-1 Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-HIV-1 Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-HIV-1 Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-HIV-1 Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-HIV-1 Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-HIV-1 Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-HIV-1 Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-HIV-1 Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-HIV-1 Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-HIV-1 Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-HIV-1 Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-HIV-1 Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-HIV-1 Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-HIV-1 Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-HIV-1 Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-HIV-1 Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-HIV-1 Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-HIV-1 Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-HIV-1 Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-HIV-1 Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Anti-HIV-1 Drugs Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Anti-HIV-1 Drugs Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck Sharp & Dohme
6.3.1 Merck Sharp & Dohme Company Information
6.3.2 Merck Sharp & Dohme Description and Business Overview
6.3.3 Merck Sharp & Dohme Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Sharp & Dohme Anti-HIV-1 Drugs Product Portfolio
6.3.5 Merck Sharp & Dohme Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Anti-HIV-1 Drugs Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Frontier Biotechnologies
6.5.1 Frontier Biotechnologies Company Information
6.5.2 Frontier Biotechnologies Description and Business Overview
6.5.3 Frontier Biotechnologies Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Frontier Biotechnologies Anti-HIV-1 Drugs Product Portfolio
6.5.5 Frontier Biotechnologies Recent Developments/Updates
6.6 Jiangsu Aidea Pharmaceutical
6.6.1 Jiangsu Aidea Pharmaceutical Company Information
6.6.2 Jiangsu Aidea Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Product Portfolio
6.6.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
6.7 Ascletis
6.7.1 Ascletis Company Information
6.7.2 Ascletis Description and Business Overview
6.7.3 Ascletis Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ascletis Anti-HIV-1 Drugs Product Portfolio
6.7.5 Ascletis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-HIV-1 Drugs Industry Chain Analysis
7.2 Anti-HIV-1 Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-HIV-1 Drugs Production Mode & Process Analysis
7.4 Anti-HIV-1 Drugs Sales and Marketing
7.4.1 Anti-HIV-1 Drugs Sales Channels
7.4.2 Anti-HIV-1 Drugs Distributors
7.5 Anti-HIV-1 Drugs Customer Analysis
8 Anti-HIV-1 Drugs Market Dynamics
8.1 Anti-HIV-1 Drugs Industry Trends
8.2 Anti-HIV-1 Drugs Market Drivers
8.3 Anti-HIV-1 Drugs Market Challenges
8.4 Anti-HIV-1 Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-HIV-1 Drugs by Type
1.2.1 Global Anti-HIV-1 Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Drugs
1.2.3 Injectable Drugs
1.3 Anti-HIV-1 Drugs by Application
1.3.1 Global Anti-HIV-1 Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Anti-HIV-1 Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-HIV-1 Drugs Revenue 2020-2031
1.4.2 Global Anti-HIV-1 Drugs Sales 2020-2031
1.4.3 Global Anti-HIV-1 Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-HIV-1 Drugs Market Competition by Manufacturers
2.1 Global Anti-HIV-1 Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-HIV-1 Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-HIV-1 Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-HIV-1 Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-HIV-1 Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-HIV-1 Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-HIV-1 Drugs, Date of Enter into This Industry
2.8 Global Anti-HIV-1 Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-HIV-1 Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-HIV-1 Drugs Players Market Share by Revenue
2.8.3 Global Anti-HIV-1 Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-HIV-1 Drugs Market Scenario by Region
3.1 Global Anti-HIV-1 Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-HIV-1 Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-HIV-1 Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-HIV-1 Drugs Sales by Region: 2026-2031
3.3 Global Anti-HIV-1 Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-HIV-1 Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-HIV-1 Drugs Revenue by Region: 2026-2031
3.4 North America Anti-HIV-1 Drugs Market Facts & Figures by Country
3.4.1 North America Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-HIV-1 Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-HIV-1 Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-HIV-1 Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-HIV-1 Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-HIV-1 Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-HIV-1 Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-HIV-1 Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-HIV-1 Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-HIV-1 Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-HIV-1 Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-HIV-1 Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-HIV-1 Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-HIV-1 Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-HIV-1 Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-HIV-1 Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-HIV-1 Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-HIV-1 Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-HIV-1 Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-HIV-1 Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-HIV-1 Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-HIV-1 Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-HIV-1 Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-HIV-1 Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-HIV-1 Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-HIV-1 Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Anti-HIV-1 Drugs Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Anti-HIV-1 Drugs Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck Sharp & Dohme
6.3.1 Merck Sharp & Dohme Company Information
6.3.2 Merck Sharp & Dohme Description and Business Overview
6.3.3 Merck Sharp & Dohme Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Sharp & Dohme Anti-HIV-1 Drugs Product Portfolio
6.3.5 Merck Sharp & Dohme Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Anti-HIV-1 Drugs Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Frontier Biotechnologies
6.5.1 Frontier Biotechnologies Company Information
6.5.2 Frontier Biotechnologies Description and Business Overview
6.5.3 Frontier Biotechnologies Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Frontier Biotechnologies Anti-HIV-1 Drugs Product Portfolio
6.5.5 Frontier Biotechnologies Recent Developments/Updates
6.6 Jiangsu Aidea Pharmaceutical
6.6.1 Jiangsu Aidea Pharmaceutical Company Information
6.6.2 Jiangsu Aidea Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Product Portfolio
6.6.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
6.7 Ascletis
6.7.1 Ascletis Company Information
6.7.2 Ascletis Description and Business Overview
6.7.3 Ascletis Anti-HIV-1 Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ascletis Anti-HIV-1 Drugs Product Portfolio
6.7.5 Ascletis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-HIV-1 Drugs Industry Chain Analysis
7.2 Anti-HIV-1 Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-HIV-1 Drugs Production Mode & Process Analysis
7.4 Anti-HIV-1 Drugs Sales and Marketing
7.4.1 Anti-HIV-1 Drugs Sales Channels
7.4.2 Anti-HIV-1 Drugs Distributors
7.5 Anti-HIV-1 Drugs Customer Analysis
8 Anti-HIV-1 Drugs Market Dynamics
8.1 Anti-HIV-1 Drugs Industry Trends
8.2 Anti-HIV-1 Drugs Market Drivers
8.3 Anti-HIV-1 Drugs Market Challenges
8.4 Anti-HIV-1 Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-HIV-1 Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-HIV-1 Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-HIV-1 Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-HIV-1 Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-HIV-1 Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-HIV-1 Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-HIV-1 Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-HIV-1 Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-HIV-1 Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-HIV-1 Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-HIV-1 Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-HIV-1 Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-HIV-1 Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-HIV-1 Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-HIV-1 Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-HIV-1 Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-HIV-1 Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-HIV-1 Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-HIV-1 Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-HIV-1 Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-HIV-1 Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-HIV-1 Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-HIV-1 Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-HIV-1 Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-HIV-1 Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-HIV-1 Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-HIV-1 Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-HIV-1 Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-HIV-1 Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-HIV-1 Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-HIV-1 Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-HIV-1 Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-HIV-1 Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-HIV-1 Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-HIV-1 Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-HIV-1 Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-HIV-1 Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Sciences Anti-HIV-1 Drugs Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Anti-HIV-1 Drugs Product
Table 79. GSK Recent Developments/Updates
Table 80. Merck Sharp & Dohme Company Information
Table 81. Merck Sharp & Dohme Description and Business Overview
Table 82. Merck Sharp & Dohme Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck Sharp & Dohme Anti-HIV-1 Drugs Product
Table 84. Merck Sharp & Dohme Recent Developments/Updates
Table 85. Cipla Company Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cipla Anti-HIV-1 Drugs Product
Table 89. Cipla Recent Developments/Updates
Table 90. Frontier Biotechnologies Company Information
Table 91. Frontier Biotechnologies Description and Business Overview
Table 92. Frontier Biotechnologies Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Frontier Biotechnologies Anti-HIV-1 Drugs Product
Table 94. Frontier Biotechnologies Recent Developments/Updates
Table 95. Jiangsu Aidea Pharmaceutical Company Information
Table 96. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 97. Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Product
Table 99. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 100. Ascletis Company Information
Table 101. Ascletis Description and Business Overview
Table 102. Ascletis Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ascletis Anti-HIV-1 Drugs Product
Table 104. Ascletis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Anti-HIV-1 Drugs Distributors List
Table 108. Anti-HIV-1 Drugs Customers List
Table 109. Anti-HIV-1 Drugs Market Trends
Table 110. Anti-HIV-1 Drugs Market Drivers
Table 111. Anti-HIV-1 Drugs Market Challenges
Table 112. Anti-HIV-1 Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-HIV-1 Drugs
Figure 2. Global Anti-HIV-1 Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-HIV-1 Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Drugs Product Picture
Figure 5. Injectable Drugs Product Picture
Figure 6. Global Anti-HIV-1 Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-HIV-1 Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Anti-HIV-1 Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anti-HIV-1 Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Anti-HIV-1 Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Anti-HIV-1 Drugs Average Price (US$/Unit) & (2020-2031)
Figure 14. Anti-HIV-1 Drugs Report Years Considered
Figure 15. Anti-HIV-1 Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Anti-HIV-1 Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Anti-HIV-1 Drugs Players: Market Share by Revenue in Anti-HIV-1 Drugs in 2024
Figure 18. Anti-HIV-1 Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Anti-HIV-1 Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 22. United States Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Anti-HIV-1 Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Anti-HIV-1 Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 41. Latin America Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Anti-HIV-1 Drugs by Type (2020-2031)
Figure 52. Global Revenue Market Share of Anti-HIV-1 Drugs by Type (2020-2031)
Figure 53. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Anti-HIV-1 Drugs by Application (2020-2031)
Figure 55. Global Revenue Market Share of Anti-HIV-1 Drugs by Application (2020-2031)
Figure 56. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2020-2031)
Figure 57. Anti-HIV-1 Drugs Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Anti-HIV-1 Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-HIV-1 Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-HIV-1 Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-HIV-1 Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-HIV-1 Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-HIV-1 Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-HIV-1 Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-HIV-1 Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-HIV-1 Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-HIV-1 Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-HIV-1 Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-HIV-1 Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-HIV-1 Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-HIV-1 Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-HIV-1 Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-HIV-1 Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Anti-HIV-1 Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-HIV-1 Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Anti-HIV-1 Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-HIV-1 Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-HIV-1 Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-HIV-1 Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-HIV-1 Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-HIV-1 Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-HIV-1 Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-HIV-1 Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-HIV-1 Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-HIV-1 Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-HIV-1 Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-HIV-1 Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-HIV-1 Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Anti-HIV-1 Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-HIV-1 Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-HIV-1 Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-HIV-1 Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-HIV-1 Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-HIV-1 Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Anti-HIV-1 Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-HIV-1 Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-HIV-1 Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-HIV-1 Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Sciences Anti-HIV-1 Drugs Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Anti-HIV-1 Drugs Product
Table 79. GSK Recent Developments/Updates
Table 80. Merck Sharp & Dohme Company Information
Table 81. Merck Sharp & Dohme Description and Business Overview
Table 82. Merck Sharp & Dohme Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck Sharp & Dohme Anti-HIV-1 Drugs Product
Table 84. Merck Sharp & Dohme Recent Developments/Updates
Table 85. Cipla Company Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cipla Anti-HIV-1 Drugs Product
Table 89. Cipla Recent Developments/Updates
Table 90. Frontier Biotechnologies Company Information
Table 91. Frontier Biotechnologies Description and Business Overview
Table 92. Frontier Biotechnologies Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Frontier Biotechnologies Anti-HIV-1 Drugs Product
Table 94. Frontier Biotechnologies Recent Developments/Updates
Table 95. Jiangsu Aidea Pharmaceutical Company Information
Table 96. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 97. Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Jiangsu Aidea Pharmaceutical Anti-HIV-1 Drugs Product
Table 99. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 100. Ascletis Company Information
Table 101. Ascletis Description and Business Overview
Table 102. Ascletis Anti-HIV-1 Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ascletis Anti-HIV-1 Drugs Product
Table 104. Ascletis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Anti-HIV-1 Drugs Distributors List
Table 108. Anti-HIV-1 Drugs Customers List
Table 109. Anti-HIV-1 Drugs Market Trends
Table 110. Anti-HIV-1 Drugs Market Drivers
Table 111. Anti-HIV-1 Drugs Market Challenges
Table 112. Anti-HIV-1 Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-HIV-1 Drugs
Figure 2. Global Anti-HIV-1 Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-HIV-1 Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Drugs Product Picture
Figure 5. Injectable Drugs Product Picture
Figure 6. Global Anti-HIV-1 Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-HIV-1 Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Anti-HIV-1 Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anti-HIV-1 Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Anti-HIV-1 Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Anti-HIV-1 Drugs Average Price (US$/Unit) & (2020-2031)
Figure 14. Anti-HIV-1 Drugs Report Years Considered
Figure 15. Anti-HIV-1 Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Anti-HIV-1 Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Anti-HIV-1 Drugs Players: Market Share by Revenue in Anti-HIV-1 Drugs in 2024
Figure 18. Anti-HIV-1 Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Anti-HIV-1 Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 22. United States Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Anti-HIV-1 Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Anti-HIV-1 Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 41. Latin America Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Anti-HIV-1 Drugs Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Anti-HIV-1 Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Anti-HIV-1 Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Anti-HIV-1 Drugs by Type (2020-2031)
Figure 52. Global Revenue Market Share of Anti-HIV-1 Drugs by Type (2020-2031)
Figure 53. Global Anti-HIV-1 Drugs Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Anti-HIV-1 Drugs by Application (2020-2031)
Figure 55. Global Revenue Market Share of Anti-HIV-1 Drugs by Application (2020-2031)
Figure 56. Global Anti-HIV-1 Drugs Price (US$/Unit) by Application (2020-2031)
Figure 57. Anti-HIV-1 Drugs Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232